NEW YORK (GenomeWeb) – Non-profit fundraising organization Stand Up to Cancer (SU2C) announced today the launch of four research projects that will use genetic and other technologies to detect and treat cancer at its earliest stages.
The projects are part of the SU2C Cancer Interception initiative and will specifically focus on lung and pancreatic cancer. They will be be funded with a total of $16.6 million provided by SU2C, the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association.